{
    "root": "e2a6b657-7429-4c8a-9a7e-c2ecf679553c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Etodolac",
    "value": "20250502",
    "ingredients": [
        {
            "name": "ETODOLAC",
            "code": "2M36281008"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "carefully consider potential benefits risks etodolac tablets treatment options deciding etodolac tablets . lowest effective dose shortest duration consistent individual patient treatment goals ( ) . etodolac tablets indicated : •for acute long-term management signs symptoms following : oosteoarthritis orheumatoid arthritis •for management acute pain",
    "contraindications": "carefully consider potential benefits risks etodolac tablets treatment options deciding etodolac tablets . lowest effective dose shortest duration consistent individual patient treatment goals ( ) . observing response initial therapy etodolac tablets , dose frequency adjusted suit individual patient 's needs . adjustment etodolac tablets generally required patients mild moderate renal impairment . etodolac used caution patients , , nsaids , may decrease renal function patients impaired renal function ( , renal effects ) .",
    "warningsAndPrecautions": "etodolac tablets usp , 400 mg available beige colored , oval shaped tablets debossed by7 one side plain side . bottles 60 ndc 68788-8580-6",
    "adverseReactions": "etodolac tablets contraindicated patients known hypersensitivity etodolac ingredients etodolac tablets . etodolac tablets given patients experienced asthma , urticaria , allergic-type taking aspirin nsaids . severe , rarely fatal , anaphylactic-like nsaids reported patients ( , anaphylactoid , pre-existing asthma ) . •in setting coronary artery bypass graft ( cabg ) surgery ( ) .",
    "indications_original": "Carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n                        WARNINGS\n                     ).\n                  Etodolac tablets are indicated:\n                  \n                     \n                        •For acute and long-term use in the management of signs and symptoms of the following: \n                           \n                              oOsteoarthritis\n                           \n                              oRheumatoid arthritis\n                        \n                     \n                     \n                        •For the management of acute pain",
    "contraindications_original": "Carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n                        WARNINGS\n                     ).\n                  After observing the response to initial therapy with etodolac tablets, the dose and frequency should be adjusted to suit an individual patient's needs.\n                  Dosage adjustment of etodolac tablets is generally not required in patients with mild to moderate renal impairment. Etodolac should be used with caution in such patients, because, as with other NSAIDs, it may further decrease renal function in some patients with impaired renal function (see \n                        WARNINGS, Renal Effects\n                     ).",
    "warningsAndPrecautions_original": "Etodolac tablets USP, 400 mg are available as beige colored, oval shaped tablets debossed BY7 on one side and plain on other side.\n                  In bottles of 60 NDC 68788-8580-6",
    "adverseReactions_original": "Etodolac tablets are contraindicated in patients with known hypersensitivity to etodolac or other ingredients in etodolac tablets.\n                  Etodolac tablets should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see \n                        WARNINGS, Anaphylactoid Reactions\n                      and \n                        PRECAUTIONS, Pre-existing Asthma\n                     ).\n                  \n                     \n                        •In the setting of coronary artery bypass graft (CABG) surgery (see \n                           WARNINGS\n                        )."
}